SEARCH

SEARCH BY CITATION

FilenameFormatSizeDescription
path4132-sup-0001-Figure S1.docWord document43KFigure S1. Leading edge diagram for carcinoma versus normal tissue, demonstrating the number of times a gene has a significant change in methylation in each set. SLIT2, the highest-ranked gene, is noted to be significantly hypermethylated in six different gene sets.
path4132-sup-0002-Figure S2.docWord document152KFigure S2. Leading edge diagram of adenoma versus normal tissue, demonstrating the number of times a gene is significantly hypomethylated within a gene set. The top-ranked gene, NDUFA13, occurs in 20 different gene sets.
path4132-sup-0003-Figure S3.docWord document27KFigure S3. Representation of GRASP/CDKN2A (p14ARF)/TP53 pathway.
path4132-sup-0004-Table S1.docWord document49KTable S1. Top 25 differentially methylated genes from Bayesian model of carcinomas versus normal tissue.
path4132-sup-0005-Table S2.docWord document49KTable S2. Top 25 differentially methylated genes from Bayesian model of adenomas versus normal tissue.
path4132-sup-0006-Table S3.docWord document49KTable S3. Top 25 differentially methylated genes from Bayesian model of carcinomas versus adenomas.
path4132-sup-0007-Table S4.docWord document37KTable S4. Table of gene set ranked by NES score for cancers versus normals in methylated probes.
path4132-sup-0008-Table S5.docWord document37KTable S5. Table of gene sets in adenomas ranked by NES score for adenomas versus normals in demethylated probes.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.